Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
QE ›
QEGRITY
Trademark search for:
QEGRITY
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-04-27 — Application filed
2017-08-17 — Sn assigned for sect 66a appl from ib
2017-08-18 — Assigned to examiner
2017-08-18 — Application filed
2017-08-21 — Approved for pub - principal register
2017-08-22 — Application filed
2017-09-13 — Notice of publication
2017-10-03 — Published for opposition
2017-10-10 — Extension of time to oppose received
2017-12-13 — Extension of time to oppose process - terminated
2018-01-16 — Registered-principal register
2018-02-15 — Grant of protection created, to be sent to ib
2018-02-15 — Final disposition recorded
2018-02-15 — Final disposition recorded
2018-03-02 — Notification processed by ib
2022-06-03 — Teas change of correspondence received
2022-06-03 — Teas change of domestic representatives address
2022-06-03 — Attorney/dom.rep.revoked and/or appointed
2022-06-03 — Applicant/correspondence changes (non-responsive) entered
2022-06-03 — Teas change of owner address received
2022-06-03 — Teas revoke/app/change addr of atty/dom rep received
2022-06-25 — New representative at ib received
2023-01-16 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2024-08-02 — Cancelled section 71
2024-08-02 — Final status recorded
2025-04-02 — Total invalidation of reg ext protection created
2025-04-14 — Teas change of domestic representatives address
2025-04-14 — Teas change of correspondence received
2025-04-14 — Teas revoke/app/change addr of atty/dom rep received
2025-04-14 — Teas withdrawal of attorney received-firm retains
2025-04-14 — Attorney/dom.rep.revoked and/or appointed
2025-07-03 — Invalidation processed
2025-07-03 — Total invalidation of reg ext protection sent to ib
2025-07-26 — Total invalidation processed by the ib
Owner Information
Astellas Pharma Inc.
Astellas Pharma Inc.
Astellas Pharma Inc.
Correspondent
Christopher Bolinger Astellas Pharma Inc.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
